Results

Total Results: 175 records

Showing results for "liver".
Users also searched for: hepatitis c

121. Final Progress Report: Improving Safety and Quality with Outpatient Order Entry (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/gandhi-report.pdf
     January 01, 2024 - Medications requiring monitoring by type of laboratory test Renal Function Thyroid Function Liver Function

122. Validation of AHRQ’s Patient Safety Indicator for Accidental Puncture or Laceration (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Gallagher1.pdf
     January 01, 2004 - repair of old obstetric laceration of rectum; Inversion of gastric diverticulum 50.6 - Repair of liver

123. Preparing for Ambulatory Computerized Prescriber Order Entry by Evaluating Preimplementation Medication Errors (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Devine.pdf
     July 01, 2003 - For example, ordering a baseline set of liver function tests prior to instituting therapy with hydroxymethyl-glutaryl

124. Serious Reportable Adverse Events in Health Care (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Kizer2.pdf
     December 01, 2000 - Excludes deaths from pulmonary or amniotic fluid embolism, acute fatty liver of pregnancy or cardiomyopathy

125. AHRQ Safety Program for MRSA Prevention: Targeting SSI
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/004-ss-antimicrobial-prophylaxis-part-2.pptx
     April 01, 2025 - PMID: 29751965. 30 | 31 Contraindications to cefazolin DRESS, AGEP, SJS/TEN25 Drug-induced liver

126. Final Progress Report: Advancing Patient Safety Innovation in Rheumatology (ASPIRE) (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/yazdany-report.pdf
     January 01, 2024 - For example, post-marketing surveillance data have suggested that rituximab can result in fulminant liver

127. Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
     February 01, 2020 - broad spectrum of serious health issues, including obstructive sleep apnea, asthma, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

128. CHIPRA 230: Documentation of BMI Percentile and Weight Classification for Children (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
     July 01, 2019 - broad spectrum of serious health issues, including obstructive sleep apnea, asthma, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

129. Final Progress Report: Incorporating Temporary Health States into Decision Support (pdf file)
     www.ahrq.gov/sites/default/files/2024-07/col-report.pdf
     January 01, 2024 - Black Cohosh Gastrointestinal pains, nausea, headaches, weight gain, constipation, liver toxicity.

130. Final Progress Report: Evaluating e-Prescribing in a Community-Based, Integrated Health System (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/devine-report.pdf
     January 01, 2024 - antihyperlipidemic medications and their corresponding laboratory values, both for safety (renal function, liver

131. Final Progress Report: Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults (pdf file)
     www.ahrq.gov/sites/default/files/2024-02/wei-report.pdf
     January 01, 2024 - diseases, hypertension, pulmonary condition, kidney disease, gastrointestinal tract disorder, and liver

132. References (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/subglottic-litreview.docx
     January 01, 2017 - congestive heart failure, chronic obstructive pulmonary disease, coronary artery disease, dementia and liver

133. What Happens After a Patient Safety Event? Medical Expenditures and Outcomes in Medicare (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Encinosa.pdf
     January 01, 2003 - Variables PSI No PSI Hypothyroidism 0.012 0.013 Renal failure 0.020 0.057 Liver disease 0.003

134. Financial and Demographic Influences on Medicare Patient Safety Events (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Bernard.pdf
     January 01, 2004 - .: Liver Disease 0.007 Peptic Ulcer Disease X Bleeding 0.010 AIDS 0.00004 Lymphoma 0.005 Metastatic

135. Pillars of a Smart, Safe Operating Room (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol3/Advances-Seagull_98.pdf
     April 07, 2008 - position of a tumor beneath the surface of a larger anatomic structure or blood vessels within the liver

136. Communication of Weight Classification for Children Who Are Overweight or Obese (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-241-bmi-communication-full-report.pdf
     February 01, 2020 - broad spectrum of serious health issues, including obstructive sleep apnea, asthma, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

137. CHIPRA Measure 240: Parent Report of Discussion of Weight Concerns for Child (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-240-bmi-parent-full-report.pdf
     February 01, 2020 - broad spectrum of serious health issues, including obstructive sleep apnea, asthma, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

138. Hypertension Screening for Children Who Are Overweight or Obese: Report (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0232-fullreport.pdf
     February 01, 2020 - serious health issues, including obstructive sleep apnea, asthma, hypertension, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

139. Chapter-7 - Harm Due to Anticoagulants (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
     March 01, 2020 - given to a patient based on specific criteria (e.g., patient characteristics such as weight, kidney or liver … Dosing protocols or nomograms may reflect different patient characteristics, such as kidney or liver

140. Final Progress Report: Risk-Informed Intervention to Improve Ambulatory Drug Monitoring and Safety (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/field-report.pdf
     January 01, 2024 - Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs.